COPD & Emphysema Support Group
COPD is a progressive disease characterized by airflow obstruction or limitation. Emphysema is characterized by loss of elasticity of the lung tissue, destruction of structures supporting the alveoli and of capillaries feeding the alveoli. Both have symptoms that include shortness of breath, among other respiratory troubles. If you are a COPD or Emphysema sufferer, join...
Anoro Ellipta should not be used to relieve a sudden attack of breathlessness or wheezing. Anoro Ellipta should not be used in patients with an intolerance to lactose or allergy to milk or any of the other ingredients within the medicine.
It is a maintenance bronchodilator treatment to relieve symptoms in Australian adult patients with chronic obstructive pulmonary disease (COPD) which is also known as “chronic bronchitis,” “smoker’s cough” or emphysema”.
If you get tightness of the chest, coughing, wheezing or breathlessness immediately after using your ANORO ELLIPTA, stop using it immediately, and seek medical help immediately.
NORO ELLIPTA is inhaled through the mouth using the ELLIPTA device. The active substances are in separate blisters in powder form inside the device. There are either 7 or 30 blisters on each strip, and so each device contains either 7 or 30 doses depending on which pack size you have been given.
The ELLIPTA device itself is a plastic inhaler with a light grey body, a red mouthpiece cover and a dose counter. It is packaged in a foil laminate tray with a peelable foil lid. The tray contains a desiccant sachet, to reduce the moisture in the packaging. Once you have opened the lid of the tray, throw the desiccant away - do not eat or inhale it.
That is about it.....So basically follow your GP or Pulmo's Instructions.....